Eagle Global Advisors’s Eli Lilly LLY Stock Holding History

Eagle Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20.7M	Sell	17,862 -83	-0.5%	-$97.9K	0.68%	36
2026 Q2	$21.5M	Buy	+17,945	New	+$18.3M	0.71%	36
2024 Q2	–	Sell	-599	Closed	-$466K	–	243
2024 Q1	$466K	Buy	599 +124	+26%	+$88.2K	0.03%	180
2023 Q4	$277K	Sell	475 -17	-3%	-$9.9K	0.02%	203
2023 Q3	$264K	Sell	492 -10	-2%	-$5.15K	0.02%	198
2023 Q2	$235K	Buy	+502	New	+$211K	0.02%	207
2017 Q3	–	Sell	-3,012	Closed	-$248K	–	312
2017 Q2	$248K	Buy	+3,012	New	+$246K	0.01%	329

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Eagle Global Advisors's LLY Position: Q3 2026 in Review

Eagle Global Advisors reduced its Eli Lilly (LLY) stake by 0.46% in Q3 2026, selling an estimated $97.9K and leaving 17,862 shares worth $20.7M. The position accounts for 0.68% of the portfolio, ranked #36.

Eagle Global Advisors first reported a position in LLY in Q2 2017 and has held it in 7 quarters since. The position peaked at $21.5M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Eagle Global Advisors held 17,862 shares of Eli Lilly worth $20.7M as of Q3 2026.
Eagle Global Advisors sold 83 Eli Lilly shares in Q3 2026, an estimated $97.9K.
Eli Lilly made up 0.68% of Eagle Global Advisors's portfolio in Q3 2026, its #36 holding.
Eagle Global Advisors first reported a position in Eli Lilly in Q2 2017 and has held it in 7 quarters since.
Eagle Global Advisors's Eli Lilly position peaked at $21.5M in Q2 2026.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Eagle Global Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.